RecruitingPhase 4ACTRN12608000476336

International Study to Predict Optimized Treatment - in Depression

International Study to Predict Optimized Treatment response to the three most commonly used antidepressants (Escitalopram, Sertraline and Venlafaxine extended release XR,) in subjects diagnosed with major depressive disorder (MDD) as compared to matched healthy controls.


Sponsor

Brain Resource

Enrollment

2,688 participants

Start Date

Jul 15, 2008

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 65 Yearss

Plain Language Summary

Simplified for easier understanding

This study is for adults with major depression who have not yet tried certain antidepressant medications. Researchers are looking for patterns in brain activity and cognitive (thinking) tests that might predict which antidepressant medication works best for a particular person. The goal is to help doctors choose the right treatment for each patient from the start, rather than through a process of trial and error. You may be eligible if: - You have been diagnosed with major depressive disorder (MDD) - Your depression score on the Hamilton Rating Scale is 16 or higher (indicating moderate to severe depression) - You are between 18 and 65 years of age - You are fluent in English or Dutch You may NOT be eligible if: - You are currently having thoughts of suicide - You have bipolar disorder, psychosis, or a primary eating disorder - You have previously used or are currently using antidepressants, specifically escitalopram, sertraline, or venlafaxine XR - You have had a head injury that caused you to lose consciousness - You have serious problems with your vision, hearing, or hand movement that would prevent you from completing tests Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Once randomised and on drug, subjects will be dosed with study medication as per local/country standard of care. Therefore, the length of treatment will differ and is based on the subjects response.

Once randomised and on drug, subjects will be dosed with study medication as per local/country standard of care. Therefore, the length of treatment will differ and is based on the subjects response. escitalopram one 10 mg tablet orally once daily (QD) sertraline one 50 mg orally QD venlafaxine extended release (XR) one 75 mg orally QD


Locations(7)

Missouri, United States of America

California, United States of America

New York, United States of America

Rhode Island, United States of America

North Carolina, United States of America

Auckland, New Zealand

Nijmegen, Netherlands

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12608000476336


Related Trials